Superstock Investor Releases November Issue; Leading Newsletter Reviews Entire Portfolio -- Jettisons Ten, Keeps Seven (BNI, WYE, MYGN, ERF, PWE, PGH and MFE)

Share Article

Superstock Investor (http://www.superstockinvestor.com) in its annual portfolio review has axed more than half of the current portfolio, reducing its tracking portfolio from 17 stocks to just seven, including: Burlington Northern Santa Fe (NYSE: BNI), Enerplus Resources Fund (NYSE: ERF), McAfee (NYSE: MFE), Myriad Genetics (Nasdaq: MYGN), Pengrowth Energy Trust (NYSE: PGH), Penn West Energy Trust (NYSE: PWE) and Wyeth (NYSE: WYE).

The rollercoaster ride the market has given us lately also provides new investors a chance to get in on some of our recommendations around the buy prices we originally set

Superstock Investor (http://www.superstockinvestor.com) in its annual portfolio review has axed more than half of the current portfolio, reducing its tracking portfolio from 17 stocks to just seven, including: Burlington Northern Santa Fe (NYSE: BNI), Enerplus Resources Fund (NYSE: ERF), McAfee (NYSE: MFE), Myriad Genetics (Nasdaq: MYGN), Pengrowth Energy Trust (NYSE: PGH), Penn West Energy Trust (NYSE: PWE) and Wyeth (NYSE: WYE).

"As the year winds down and people take stock (no pun intended) of what they've accomplished, part of the process should be shifting and rebalancing the financial positions they hold; we here at Superstock Investor are no different. Each stock in our portfolio regularly goes through a very stringent analysis and this is a very exciting time of year to rebalance," said James DiGeorgia, executive editor and publisher of Superstock Investor.

"The rollercoaster ride the market has given us lately also provides new investors a chance to get in on some of our recommendations around the buy prices we originally set," DiGeorgia continued. "We believe that PenGrowth (PGH), PennWest (PWE), and Enerplus Resources Fund (ERF) are still very attractively priced. Additionally, we would recommend any of the other remaining positions in our tracking portfolio should they dip to the original buy price."

Superstock Investor's goal is to provide subscribers a steady stream of original stock ideas with an emphasis on takeover candidates. These are companies that Superstock Investor has identified as potential takeover targets, or special situations with some catalyst promising to send their shares soaring.

Positions that were closed out of the Superstock Investor portfolio include: Aspect Medical Systems (Nasdaq: ASPM), Bradley Pharmaceuticals (NYSE: BDY), Liz Claiborne (NYSE: LIZ), Protection One (Nasdaq: PONE), and PrimeWest Energy Trust (NYSE: PWI).

"Some of those positions did very well for us. PrimeWest tallied a 40% gain in just eight months. But when a position no longer holds the promise we think it initially does, we let our subscribers know to take their profits now. We use our annual review issue to reexamine the underlying fundamentals of each recommendation we've made," DiGeorgia concluded.

Superstock Investor (SSI) is not a registered broker/dealer and may not sell, offer to sell or offer to buy any security. SSI profiles are not a solicitation or recommendation to buy, sell or hold securities. An offer to buy or sell can be made only with accompanying disclosure documents from the company offering or selling securities and only in the states and provinces for which they are approved. The material in this release is intended to be strictly informational. The companies that are discussed in this release have not approved the statements made in this release nor approved the timing of this release. All statements and expressions are the sole opinion of SSI and are subject to change without notice. Information in this release is derived from a variety of sources including that company's publicly disseminated information, third parties and SSI research. The accuracy or completeness of the information is not warranted and is only as reliable as the sources from which it was obtained. SSI disclaims any and all liability as to the completeness or accuracy of the information contained and any omissions of material fact in this release. The release may contain technical inaccuracies or typographical errors. It is strongly recommended that any purchase or sale decision be discussed with a financial adviser, or a broker-dealer, or a member of any financial regulatory bodies. Investment in the securities of the companies discussed in this release is highly speculative and carries a high degree of risk. SSI is not liable for any investment decisions by its readers or subscribers. Investors are cautioned that they may lose all or a portion of their investment if they make a purchase in SSI profiled stocks. This profile is without bias, and SSI has not been compensated for dissemination of company information on behalf of any of the companies mentioned in this release.

This release contains "forward-looking statements" within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E the Securities Exchange Act of 1934, as amended and such forward-looking statements are made pursuant to the safe harbor provisions of the Private Securities Litigation Reform Act of 1995. "Forward-looking statements" describe future expectations, plans, results, or strategies and are generally preceded by words such as "may," "future," "plan" or "planned," "will" or "should," "expected," "anticipates," "draft," "eventually" or "projected." You are cautioned that such statements are subject to a multitude of risks and uncertainties that could cause future circumstances, events, or results to differ materially from those projected in the forward-looking statements, including the risks that actual results may differ materially from those projected in the forward-looking statements as a result of various factors, and other risks identified in a company's annual report on Form 10-K or 10-KSB and other filings made by such company with the Securities and Exchange Commission. You should consider these factors in evaluating the forward-looking statements included herein, and not place undue reliance on such statements. The forward-looking statements in this release are made as of the date hereof and SSI undertakes no obligation to update such statements.

###

Share article on social media or email:

View article via:

Pdf Print

Contact Author

Noah Davis
Visit website